Sign up to save your podcasts
Or
Share Théa Completes Acquisition of ProQR’s LCA10 and USH2A Treatment Programs
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Théa Completes Acquisition of ProQR’s LCA10 and USH2A Treatment Programs
Known as antisense oligonucleotides, the treatments performed encouragingly in ProQR’s clinical trials
View all episodes
By Foundation Fighting Blindness
4.9
2525 ratings
Known as antisense oligonucleotides, the treatments performed encouragingly in ProQR’s clinical trials
More shows like Foundation Fighting Blindness
View all
Fresh Air
38,544 Listeners
The Joe Rogan Experience
229,631 Listeners
Planet Money
30,715 Listeners
Making Sense with Sam Harris
26,408 Listeners
Pivot
9,750 Listeners
Science Friday
6,438 Listeners
The Daily
113,075 Listeners
The Jordan Harbinger Show
11,987 Listeners
The Journal.
6,127 Listeners
The Prof G Pod with Scott Galloway
5,663 Listeners
All-In with Chamath, Jason, Sacks & Friedberg
10,192 Listeners
SmartLess
58,474 Listeners
The Bible in a Year (with Fr. Mike Schmitz)
62,662 Listeners
Huberman Lab
29,300 Listeners
The Ezra Klein Show
16,492 Listeners